Total Payments
$3,178
2024 Payments
$89.57
Companies
22
Transactions
85
Medicare Patients
3,298
Medicare Billing
$348,213
Payment Breakdown by Category
Food & Beverage$3,178 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,178 | 85 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $972.42 | 10 | $0 (2024) |
| Astellas Pharma US Inc | $500.36 | 5 | $0 (2019) |
| Sun Pharmaceutical Industries Inc. | $432.01 | 21 | $0 (2023) |
| PFIZER INC. | $387.78 | 11 | $0 (2020) |
| Galderma Laboratories, L.P. | $166.64 | 7 | $0 (2023) |
| EPI Health, LLC | $149.69 | 6 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $78.17 | 1 | $0 (2018) |
| Incyte Corporation | $68.78 | 3 | $0 (2024) |
| Janssen Biotech, Inc. | $62.37 | 3 | $0 (2024) |
| Taro Pharmaceuticals USA, Inc. | $62.11 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $89.57 | 4 | Incyte Corporation ($41.64) |
| 2023 | $219.60 | 9 | Galderma Laboratories, L.P. ($76.98) |
| 2022 | $235.18 | 11 | Sun Pharmaceutical Industries Inc. ($142.44) |
| 2021 | $293.73 | 14 | SUN PHARMACEUTICAL INDUSTRIES INC. ($159.60) |
| 2020 | $428.60 | 9 | PFIZER INC. ($197.95) |
| 2019 | $553.24 | 12 | AbbVie, Inc. ($249.99) |
| 2018 | $830.75 | 18 | AbbVie, Inc. ($339.86) |
| 2017 | $526.96 | 8 | Astellas Pharma US Inc ($240.40) |
All Payment Transactions
85 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/29/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $15.39 | General |
| Category: Dermatology | ||||||
| 08/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: IMMUNOLOGY | ||||||
| 05/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Immunology | ||||||
| 05/09/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $26.25 | General |
| Category: Dermatology | ||||||
| 10/24/2023 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: DERMATOLOGY | ||||||
| 08/03/2023 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $23.32 | General |
| 07/13/2023 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: ONCOLOGY | ||||||
| 07/05/2023 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $30.32 | General |
| Category: Dermatology | ||||||
| 06/08/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: Immunology | ||||||
| 04/20/2023 | Journey Medical Corporation | — | Food and Beverage | In-kind items and services | $27.72 | General |
| 03/09/2023 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $25.87 | General |
| Category: Dermatology | ||||||
| 03/08/2023 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $24.87 | General |
| 01/17/2023 | Galderma Laboratories, L.P. | AKLIEF (Drug), ORACEA, TWYNEO | Food and Beverage | In-kind items and services | $28.79 | General |
| Category: ACNE | ||||||
| 09/27/2022 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $31.47 | General |
| Category: Dermatology | ||||||
| 09/01/2022 | Journey Medical Corporation | QBREXZA (Drug), Accutane | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: Dermatology | ||||||
| 08/04/2022 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $32.91 | General |
| Category: Dermatology | ||||||
| 07/26/2022 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $6.80 | General |
| Category: Dermatology | ||||||
| 06/28/2022 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $9.32 | General |
| Category: Dermatology | ||||||
| 05/19/2022 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $22.18 | General |
| 04/28/2022 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Dermatology | ||||||
| 03/31/2022 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Dermatology | ||||||
| 03/02/2022 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Immunology | ||||||
| 02/08/2022 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $27.14 | General |
| Category: Dermatology | ||||||
| 01/05/2022 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Dermatology | ||||||
| 12/14/2021 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $6.90 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 846 | 1,823 | $170,875 | $103,647 |
| 2022 | 10 | 890 | 1,631 | $155,785 | $91,446 |
| 2021 | 10 | 867 | 1,563 | $151,370 | $92,269 |
| 2020 | 10 | 695 | 1,186 | $113,930 | $60,851 |
Total Patients
3,298
Total Services
6,203
Medicare Billing
$348,213
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 208 | 438 | $88,770 | $63,760 | 71.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 78 | 134 | $16,825 | $12,616 | 75.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 67 | 67 | $23,450 | $11,530 | 49.2% |
| 53661 | Subsequent dilation of urethra in female | Office | 2023 | 49 | 95 | $9,500 | $6,178 | 65.0% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 245 | 658 | $13,160 | $2,593 | 19.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 17 | $5,850 | $2,470 | 42.2% |
| 87210 | Smear for infectious agents | Office | 2023 | 139 | 340 | $6,800 | $1,938 | 28.5% |
| 51701 | Insertion of temporary bladder tube | Office | 2023 | 15 | 39 | $4,175 | $1,504 | 36.0% |
| 53660 | Initial dilation of urethra in female | Office | 2023 | 13 | 13 | $1,900 | $874.77 | 46.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 19 | 22 | $445.00 | $184.80 | 41.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 180 | 301 | $63,350 | $43,065 | 68.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 113 | 206 | $25,750 | $19,774 | 76.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 83 | 83 | $29,050 | $13,935 | 48.0% |
| 53661 | Subsequent dilation of urethra in female | Office | 2022 | 47 | 86 | $8,600 | $5,636 | 65.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 17 | 19 | $6,650 | $3,172 | 47.7% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2022 | 254 | 571 | $11,420 | $2,263 | 19.8% |
| 87210 | Smear for infectious agents | Office | 2022 | 141 | 302 | $6,040 | $1,732 | 28.7% |
| 53660 | Initial dilation of urethra in female | Office | 2022 | 16 | 16 | $2,400 | $1,090 | 45.4% |
| 51701 | Insertion of temporary bladder tube | Office | 2022 | 13 | 18 | $1,800 | $692.09 | 38.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 26 | 29 | $725.00 | $85.68 | 11.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 179 | 298 | $59,750 | $43,614 | 73.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 95 | 168 | $21,000 | $15,900 | 75.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 84 | 84 | $29,300 | $15,382 | 52.5% |
| 53661 | Dilation of bladder canal (urethra), female, subsequent | Office | 2021 | 51 | 99 | $9,900 | $6,712 | 67.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 21 | 25 | $8,750 | $4,283 | 48.9% |
About Dr. Kiumars Bakshandeh, M.D
Dr. Kiumars Bakshandeh, M.D is a Specialist healthcare provider based in Beverly Hills, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700945144.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kiumars Bakshandeh, M.D has received a total of $3,178 in payments from pharmaceutical and medical device companies, with $89.57 received in 2024. These payments were reported across 85 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($3,178).
As a Medicare-enrolled provider, Bakshandeh has provided services to 3,298 Medicare beneficiaries, totaling 6,203 services with total Medicare billing of $348,213. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Beverly Hills, CA
- Active Since 12/08/2006
- Last Updated 07/09/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1700945144
Products in Payments
- XTANDI (Drug) $571.31
- Lupron (Drug) $443.27
- Lupron Depot (Drug) $249.99
- Winlevi (Drug) $248.99
- Xtandi (Drug) $240.40
- LUPRON DEPOT (Drug) $149.90
- Sitavig (Drug) $130.97
- Absorica LD (Drug) $109.24
- Androgel (Drug) $101.74
- FARXIGA (Drug) $78.17
- TOVIAZ (Drug) $76.43
- OPZELURA (Drug) $68.78
- ULTRAVATE (halobetasol propionate) lotion (Drug) $43.70
- TREMFYA (Drug) $42.74
- ENSTILAR (Drug) $41.50
- ABSORICA LD (Drug) $39.41
- QBREXZA (Drug) $35.04
- AKLIEF (Drug) $28.79
- RINVOQ (Biological) $27.52
- Acticlate (Drug) $23.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Beverly Hills
Dr. Norman Lepor, M.d, M.D
Specialist — Payments: $3.0M
Specialist $3.0M
Dr. Michael Bush, M.d, M.D
Specialist — Payments: $614,437
Specialist $614,437
Dr. Stuart Silverman, Md, MD
Specialist — Payments: $572,532
Specialist $572,532
Dr. Suzanne Gilberg-Lenz, M.d, M.D
Specialist — Payments: $319,119
Specialist $319,119
Dr. Todd Lanman, M.d., F.a.c.s, M.D., F.A.C.S
Specialist — Payments: $308,676
Specialist $308,676
Dr. Hooman Melamed, M.d, M.D
Specialist — Payments: $202,585
Specialist $202,585